Acadia Pharmaceuticals Inc. · 1 day ago
Cyber Risk Analyst
San Diego, CA
Full-time
Hybrid
Mid Level
$29.33/hr - $36.59/hr
3+ years expAcadia Pharmaceuticals Inc. is dedicated to creating innovative treatments for underserved neurological and rare disease communities. The Cyber Risk Analyst will develop, implement, and monitor a comprehensive cybersecurity and cyber risk management program, while being an active member of risk management committees.
BiotechnologyHealth CarePharmaceutical
Responsibilities
Conduct risk assessments and audits of IT systems, applications, and third-party vendors
Perform contract reviews with a focus on cybersecurity terms and third-party risk implications
Develop and maintain risk registers, mitigation plans, and incident response strategies
Perform and maintain Business Impact Analysis (BIA) of key systems and vendors
Maintain the Business Continuity and Disaster Recovery Plan (BCDRP)
Collaborate with stakeholders across Legal/Compliance/Privacy, Procurement, IT, and various business units to implement security controls and improve overall risk posture
Maintain and enhance Governance, Risk, and Compliance (GRC) tools, such as OneTrust
Align cyber risk activities with relevant regulatory requirements (CCPA, U.S. SEC, GDPR, NIS 2 Directive, etc.)
Support SOX and ITGC compliance efforts, including audit preparation, evidence collection, and control testing
Contribute to the development and maintenance of security policies, procedures, and training programs
Prepare risk reports for senior leadership and non-technical stakeholders, translating technical findings into business-relevant insights
Ensures that all actions, both internally and externally, working on Acadia’s behalf are in compliance with all laws regulations, policies and demonstrates Acadia values
Other responsibilities as assigned
Qualification
Required
Bachelor's degree in Cybersecurity, Information Systems, Risk Management, or a related field
Targeting 3 years of progressively responsible experience in cyber risk, information security, or IT audit
Proven ability to conduct risk assessments and audits of IT systems, applications, and third-party vendors
Strong understanding of regulatory frameworks and standards including NIST, ISO 27001, SOX, GDPR, NIS 2 Directive, and FAIR
Skilled in developing and maintaining risk registers, mitigation plans, and incident response strategies
Proficient in GRC platforms such as OneTrust, with experience in tool configuration and workflow optimization
Strong analytical, organizational, and communication skills
Skills to translate technical risk findings into actionable insights for senior leadership and non-technical stakeholders
Ability to manage multiple priorities and work cross-functionally in a fast-paced environment
Ability to travel on occasions
Must be able and willing to travel on occasion
Preferred
Advanced certifications (CISM/CRISC/CISA/FAIR/CISSP) strongly preferred
An equivalent combination of relevant education and experience may be considered
Benefits
Medical, dental, and vision insurance
Employer-paid life, disability, business travel and EAP coverage
401(k) Plan with a fully vested company match 1:1 up to 5%
Employee Stock Purchase Plan with a 2-year purchase price lock-in
15+ vacation days
13 -15 paid holidays, including office closure between December 24th and January 1st
10 days of paid sick time
Paid parental leave benefit
Tuition assistance
Company
Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals develops and commercializes small molecule drugs for the treatment of central nervous system disorders.
501-1000 employees
H1B Sponsorship
Acadia Pharmaceuticals Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2021 (1)
Funding
Current Stage
Public CompanyTotal Funding
$811.73MKey Investors
National Institute of Neurological Disorders and StrokeOxford Bioscience PartnersNational Institute of Mental Health
2019-09-17Post Ipo Equity· $287.5M
2018-11-30Post Ipo Equity· $316.25M
2013-01-02Post Ipo Equity· $86.39M
Leadership Team
Catherine Adams
Chief Executive Officer
Steve Davis
President and CEO
Recent News
2025-11-20
Company data provided by crunchbase